Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001883850-22-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-12-13 | 2022-10-26 | REGN | Fenimore Christopher R. | SVP Ctrl | G - Gift | $0.00 | 0 | 461 | New | $0 |
| 2022-12-13 | 2022-12-09 | REGN | Fenimore Christopher R. | SVP Ctrl | F - Tax | $753.28 | -247 | 16.7K | -1% | -$186.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-26 | G | A | 435 | $0.00 | 460 | I | — | — | |
| 2 | Common | Common Stock | 2022-10-26 | G | D | 871 | $0.00 | 0 | I by Trust for Daugh | — | — | |
| 3 | Common | Common Stock | 2022-12-09 | F | D | 247 | $753.28 | 16,655 | D by 2018 GRAT | — | — | |
| 4 | Common | Common Stock | 2022-10-26 | G | A | 436 | $0.00 | 461 | I by Trust for Son | — | — |